- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Patent holdings for IPC class A61K 47/60
Total number of patents in this class: 3321
10-year publication summary
72
|
142
|
248
|
391
|
471
|
459
|
486
|
465
|
413
|
122
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Nektar Therapeutics | 503 |
93 |
Hanmi Pharm. Co., Ltd. | 546 |
71 |
The Regents of the University of California | 18943 |
53 |
Bristol-myers Squibb Company | 5080 |
45 |
Ascendis Pharma A/S | 173 |
45 |
Massachusetts Institute of Technology | 9795 |
37 |
The Johns Hopkins University | 5377 |
37 |
Board of Regents, The University of Texas System | 5370 |
35 |
Synthorx, Inc. | 69 |
30 |
Quiapeg Pharmaceuticals AB | 46 |
27 |
Ascendis Pharma Growth Disorders A/S | 36 |
27 |
Amgen Inc. | 3779 |
23 |
Janssen Pharmaceutica N.V. | 3839 |
22 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
20 |
Ascendis Pharma Bone Diseases A/S | 39 |
20 |
Northwestern University | 3112 |
19 |
NOK Corporation | 2108 |
19 |
ProLynx LLC | 54 |
19 |
Takeda Pharmaceutical Company Limited | 2961 |
17 |
Ambrx, Inc. | 191 |
17 |
Other owners | 2645 |